
Top Stock Reports for Disney, Morgan Stanley & Stryker

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Thursday, March 21, 2024
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Co. (DIS), Morgan Stanley (MS) and Stryker Corp. (SYK). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Disney's shares have outperformed the Zacks Media Conglomerates industry over the past year (+22.7% vs. +6.8%). The Zacks analyst believes that recent attractions in places like Hong Kong and Paris should boost the company’s theme park business.
However, declining ad revenues, increasing programming and production costs at Media and Entertainment Distribution segments and stiff competition in the streaming market remain major tailwinds.
(You can read the full research report on Disney here >>>)
Morgan Stanley’s shares have underperformed the Zacks Financial – Investment Bank industry over the last six months (+9.7% vs. +20.0%). The Zacks analyst believes that volatility in the capital markets has continued to hurt the company’s Institutional Securities segment. Also, elevated costs are likely to impact profitability.
Yet, Morgan Stanley’s trading and investment banking segments turned around slightly in the fourth quarter of 2023. The company's brand-new strategic alliance with Mitsubishi UFJ will bolster its presence in Japan. Also, inorganic expansion efforts will aid.
(You can read the full research report on Morgan Stanley here >>>)
Shares of Stryker have outperformed the Zacks Medical - Products industry over the past year (+29.7% vs. +6.6%). Per the Zacks analyst, strong business in the United States as well as globally have created optimism about the company’s prospects. Heavy demand for the company’s existing product line as well as new launches have also aided.
However, inflationary pressure and supply-chain challenges continue to plague Stryker. Stiff competition in the MedTech space also remains a headwind.
(You can read the full research report on Stryker here >>>)
Other noteworthy reports we are featuring today include Shopify Inc. (SHOP), MetLife, Inc. (MET) and Delta Air Lines, Inc. (DAL).
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Get the latest research report on MS - FREE
Get the latest research report on DAL - FREE
Get the latest research report on SYK - FREE
Get the latest research report on MET - FREE
Get the latest research report on DIS - FREE
Get the latest research report on SHOP - FREE